These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 19558959)
1. [Proposal for a diagnostic algorithm for the use of (18)F-FDG-PET in lung cancer]. Borrego-Dorado I; Vázquez-Albertino R Rev Esp Med Nucl; 2009; 28(3):167-72. PubMed ID: 19558959 [No Abstract] [Full Text] [Related]
2. [Positron-emission tomography in the evaluation of lung cancer]. Torres García AJ; Carreras Delgado JL Arch Bronconeumol; 1997 Dec; 33(11):553-5. PubMed ID: 9508470 [No Abstract] [Full Text] [Related]
3. 18-fluorine fluorodeoxyglucose positron emission tomography with computerized tomography versus computerized tomography alone for the management of solitary lung nodules with diameters inferior to 1.5 cm. Divisi D; Di Tommaso S; Di Leonardo G; Brianzoni E; De Vico A; Crisci R Thorac Cardiovasc Surg; 2010 Oct; 58(7):422-6. PubMed ID: 20922626 [TBL] [Abstract][Full Text] [Related]
4. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules. Bryant AS; Cerfolio RJ Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527 [TBL] [Abstract][Full Text] [Related]
5. Hypermetabolism on F-18 FDG PET of multiple pulmonary nodules resulting from bronchiolitis obliterans organizing pneumonia. Shin L; Katz DS; Yung E Clin Nucl Med; 2004 Oct; 29(10):654-6. PubMed ID: 15365446 [No Abstract] [Full Text] [Related]
6. Combined contrast-enhanced computed tomography and 18-fluoro-2-deoxy-D-glucose-positron emission tomography in the diagnosis and staging of non-small cell lung cancer. Allen TL; Kendi AT; Mitiek MO; Maddaus MA Semin Thorac Cardiovasc Surg; 2011; 23(1):43-50. PubMed ID: 21807298 [TBL] [Abstract][Full Text] [Related]
7. 18Fluorodeoxyglucose positron emission tomography, a standard diagnostic tool in lung cancer. Giaccone G J Natl Cancer Inst; 2007 Dec; 99(23):1741-3. PubMed ID: 18042929 [No Abstract] [Full Text] [Related]
9. PET for the evaluation of solitary pulmonary nodules. Fisher RE J Nucl Med; 2009 Feb; 50(2):326; author reply 326-7. PubMed ID: 19164230 [No Abstract] [Full Text] [Related]
10. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients. Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients. Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912 [TBL] [Abstract][Full Text] [Related]
12. Use of FDG PET/CT in Patients with Pancoast Tumors: Does It Add Any Contribution to Patient Management? Ozmen O; Yilmaz U; Dadali Y; Tatci E; Gokcek A; Aydin E; Okuyucu K; Arslan N Cancer Biother Radiopharm; 2015 Oct; 30(8):359-67. PubMed ID: 26367245 [TBL] [Abstract][Full Text] [Related]
13. FDG uptake heterogeneity evaluated by fractal analysis improves the differential diagnosis of pulmonary nodules. Miwa K; Inubushi M; Wagatsuma K; Nagao M; Murata T; Koyama M; Koizumi M; Sasaki M Eur J Radiol; 2014 Apr; 83(4):715-9. PubMed ID: 24418285 [TBL] [Abstract][Full Text] [Related]
14. [Use of positron-emission tomography with F18-fluorodeoxyglucose for the assessment of lung lesions suspicious of malignancy]. Jofré MJ; Massardo T; González P; Canessa J; Sierralta P; Humeres P; Galaz R; Valdebenito R Rev Med Chil; 2005 May; 133(5):583-92. PubMed ID: 15970984 [TBL] [Abstract][Full Text] [Related]
15. PET/CT in non-small cell lung cancer staging-promises and problems. Devaraj A; Cook GJ; Hansell DM Clin Radiol; 2007 Feb; 62(2):97-108. PubMed ID: 17207691 [TBL] [Abstract][Full Text] [Related]
16. Impact of 18F-FDG PET/CT in the treatment of patients with non-small cell lung cancer. Taus Á; Aguiló R; Curull V; Suárez-Piñera M; Rodríguez-Fuster A; Rodríguez de Dios N; Pijuan L; Zuccarino F; Vollmer I; Sánchez-Font A; Belda-Sanchis J; Arriola E Arch Bronconeumol; 2014 Mar; 50(3):99-104. PubMed ID: 24360985 [TBL] [Abstract][Full Text] [Related]
17. PET scanning said to save money and improve staging of lung cancer. Oncology (Williston Park); 1995 Nov; 9(11):1200. PubMed ID: 8703689 [No Abstract] [Full Text] [Related]
18. Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules. Lee ST; Berlangieri SU; Poon AM; Mitchell P; Pathmaraj K; Tabone K; Byrne AJ; O'Keefe GJ; Knight SR; Clarke CP; Scott AM Intern Med J; 2007 Nov; 37(11):753-9. PubMed ID: 17517082 [TBL] [Abstract][Full Text] [Related]
19. Radiological experience needed when assessing PET/CT imaging. Liu W; Liang W Thorac Cardiovasc Surg; 2011 Aug; 59(5):317; author reply 318. PubMed ID: 21472674 [No Abstract] [Full Text] [Related]
20. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules. Daniels CE; Lowe VJ; Aubry MC; Allen MS; Jett JR Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]